Alexandria, LANCT07335861Now EnrollingIRB Ready

Venous Leg Ulcer Clinical Trial in Alexandria, LA

Access cutting-edge venous leg ulcer treatment through this clinical trial at a research site in Alexandria. Study-provided care at no cost to qualified participants.

Sponsored by NuScience Medical Biologics, LLC

Quick Self-Assessment

See if you qualify for this Alexandria location

Preparing your pre-screening questions…

Expert Care in Alexandria

Access venous leg ulcer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related venous leg ulcer treatment provided free

Apply for This Alexandria Location

Check if you qualify for this venous leg ulcer clinical trial in Alexandria, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Alexandria

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Alexandria site if eligible
  4. 4Begin participation

About This Venous Leg Ulcer Study in Alexandria

This is a randomized controlled trial evaluating the efficacy of HYALOMATRIX in conjunction with standard of care vs. standard of care alone in treating venous leg ulcers.

Sponsor: NuScience Medical Biologics, LLC

Who Can Participate

Inclusion Criteria

Male or Female, 18 years of age or older
Subject has a medical diagnosis of venous leg ulcer or venous insufficiency with a lower extremity wound
Subject has a venous leg ulcer present for 4 weeks or greater (documented in medical record), and less than 12 months duration if being treated with continuous SOC
Subject has a venous leg ulcer with a historical wound measurement showing less than 25% healing within 14 days prior to screening
Subject has a venous leg ulcer with screening wound measurement showing less than 25% healing within 14 days prior to randomization
Subject has a venous leg ulcer without infection or clinically visible exposed bone
Index wound is a minimum of 1 cm2 and a maximum of 30 cm2 at first treatment visit
Adequate circulation if wound is location on the lower extremity demonstrated by an ABI of \>0.7 and \<1.3, or TBI of \>0.6 within 30 days prior to informed consent OR an arterial ultrasound noted with patent circulation and without significant stenosis 90 days prior to the first treatment visit.
Venous Leg Ulcer is being treated with compression therapy for 14 days prior to treatment visit 1
Index wound is free of necrotic debris prior to Hyalomatrix application
Female subjects of childbearing potential having a negative pregnancy test prior to randomization
Index wound is free of infection prior to randomization and during screening phase noted with the NERDS Assessment. Infection must be adequately treated and controlled prior to randomization.
Subject is able and willing to follow the protocol requirements
Subject had signed informed consent
If 2 or more wounds are present, the wounds must be separated by at least 2 cm

Exclusion Criteria

Subject does not have a diagnosis of venous leg ulcer or venous insufficiency with a wound located on the lower extremity
Subject has a known life expectancy of \<1 year
Subject is unable to comply with protocol treatment
Subject has comorbid conditions that may compromise subject safety or wound healing in the opinion of the investigator, such as serious cardiovascular, renal, liver, pulmonary, autoimmune, palliative care, or inherited blood disorders
Subject actively being treated for malignant disease or history of malignancy or radiation therapy at the site of wound
Subject has comorbid conditions that may compromise subject safety in the opinion of the investigator
Known contraindications to tissue-engineered allograft
Concurrent participation in alternative clinical trial that involves investigational drug or HCT/P interfering with wound treatment and/or healing.
Subject is pregnant or breastfeeding
Subject with history of immunosuppressant treatment (systemic corticosteroids \>10mg daily dose), cytotoxic chemotherapy, or topical steroid application to the wound surface for \>2 weeks duration within 30 days prior to randomization; or anticipated use of the above during the course of the study
Wound previously treated with CAMPs, tissue engineered, or scaffold materials within 30 days prior to randomization
Venous leg ulcer with active infection
Wound depth with visible exposed bone
HBOT within 14 days prior to randomization
Revascularization surgery on the index wound leg within 30 days of screening phase
Index wound suspicious of neoplasm in the opinion of the principal investigator

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Alexandria?

Yes, this clinical trial (NCT07335861) has an active research site in Alexandria, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Venous Leg Ulcer Treatment Options in Alexandria, LA

If you're searching for venous leg ulcer treatment options in Alexandria, LA, this clinical trial (NCT07335861) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Alexandria research site is actively enrolling participants for this clinical trial. You'll receive care from experienced venous leg ulcer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Alexandria?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Alexandria, LA